Week 10

In this blog, I will talk about our UC Davis Patent, as I am very excited about the potential it has to be commercialized. However, I do not have a lot of specific information available to talk about, as the patent is currently pending. We have reached out to UC Davis for more information about the patent, and have in fact received a response from their IP lawyers about how to move forward with learning more about the patent. Hopefully, by next week, I will have more information for you about the patent specifics.

Regardless, our patent seems to revolve around a wearable device that uses Galvanic Skin Response (a sweat sensor), Heart Rate Sensors, and Heart Rate Variability Sensors in order to determine information about the wearer’s emotional responses to internal and external stimuli. According to the patent’s description, the wearable that was developed for this device is a glove that can be worn and has the sensors embedded in the device. The inventors of the device have said that the device is meant to help individuals with Autistic Spectrum Disorder, as a core symptom of the disorder is the inability to understand one’s own and others’ emotional responses. By using a wearable that helps determine emotional responses, people with ASD may be able to better adjust their responses and understand social situations around them.


Unfortunately, this is all the information provided to me at the time. By next week, I hope to be able to provide you with a full breakdown of our patent’s claims and novel discoveries.

Comments

Post a Comment

Popular posts from this blog

Week 6

Week 6 Hi, My name is Kush Rastogi and this is my private blog for IEOR 185. To this point, my team, Pied Piper, has been working well together, but our project is facing some major hurdles. In the past few weeks, we decided on using the famous CRISPR patent championed by Professor Doudna, but we have had difficulty reaching out to the CRISPR team for more comments on the patent and how we could potentially turn it into a business. This is a little concerning to me as it seems many other teams have already selected their patent and have the wishful blessings of the professors whose research the patent came from.  However, just this week, I was able to talk to individuals from Berkeley IPIRA who handle all inquiries related to valuable Berkeley IP. According to these individuals, a company based off of the CRISPR patent would need to have significant capital to begin with, and therefore any startup involved with this work would most likely not be able to provide any th...
Read more

Week 12

This week, we conducted a lot of market research regarding our product and found out some good and bad news in our field. On one hand, we have received lots of valuable information from UC Davis that allows us to really get into the finer points of developing our product, but on the other hand, we have found out that there are some existing companies in this field that do similar work. One of the companies that we are particularly worried about is Empatica. They develop a wristband that uses similar sensors as our wearable to measure emotions (note their name - empathy). However, while we may target Autism or the general population, Empatica targets patients with epilepsy specifically. As such, though our products are similar, it is possible we could outmaneuver Empatica by focusing on a different market or by championing the technology for the public at large. In order to become presentation-ready, I think we need to focus on how our company is different from the rest of the comp...
Read more

Week 11

For this blog post, we have been asked to answer the question: What keeps us up at night regarding our project? I think the factor that keeps me up the most at night regarding our project is how to properly go to market with our product. As our patent relates to Autism, one of the paths we can take is to market the wearable towards individuals with ASD. One of the problems with this path is that it severely limits our potential market base, and also may begin to stigmatize our product. This would be quite unfortunate, as the purpose of our product is to help people understand their emotions, not to make them feel cornered into a medical prognosis. An alternative that we have discussed is making the product available for children with ASD in schools. While this does in fact limit our market further, the smallness of this market may serve to help us as it makes it easier for us to establish milestones and quickly expand to corner the entire market. Other options that we have discuss...
Read more